Hanaoka, H., Iida, H., Kiyokawa, T., Takakuwa, Y., & Kawahata, K. (2019). Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus. Intern Med.

Hanaoka, Hironari, Harunobu Iida, Tomofumi Kiyokawa, Yukiko Takakuwa, i Kimito Kawahata. "Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients With Systemic Lupus Erythematosus." Intern Med 2019.

Hanaoka, Hironari, et al. "Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients With Systemic Lupus Erythematosus." Intern Med 2019.